Back

ROSEFINCH PHARMACEUTIQUE PRIVATE LIMITED

REGISTERED OFFICE: SURVEY NO. 473, VILLAGE MALAVIYA PIPARIYA, TALUKA LATHI, DISTRICT AMRELI - 365430, GUJ. CORPORATE OFFICE: OFFICE NO 210, 2ND FLOOR, MADHAVA COMMERCIAL PREMISES CSL, C-4, E BLOCK BKC, NEAR JIO WORLD DRIVE, BANDRA KURLA COMPLEX, BANDRA EAST, MUMBAI, MAHARASHTRA 400051, INDIA

Product Categories

Formulations
ACECLOFENAC (100 MG)+ PARACETAMOL (325 MG),ALLOPURINOL (100 MG),ALLOPURINOL (300 MG),AZITHROMYCIN (250 MG),AZITHROMYCIN (500 MG),CALCIUM (500 MG) + VITAMIN D3 (100 IU),DICLOFENAC (50 MG) + PARACETAMOL (325 MG),DOMPERIDONE (30 MG) + RABEPRAZOLE (20 MG),ITRACONAZOLE (100 MG),OMEPRAZOLE (20 MG),ONDANSETRON (2 MG),TELMISARTAN (40 MG) + AMLODIPINE (10 MG),TELMISARTAN (40 MG) + HYDROCHLOROTHIAZIDE (12.5 MG)
1) PHENYLEPHRINE (5 MG), CHLORPHENIRAMINE MALEATE (2 MG), DEXTROMETHORPHAN HYDROBROMIDE (15 MG) SYRUP 2) AMBROXOL (30 MG), LEVOSALBUTAMOL (1 MG), GUAIFENESIN (50 MG) SYRUP 3) AMBROXOL (15 MG), GUAIFENESIN (50 MG), TERBUTALINE (1.25 MG) SYRUP 4) PHENYLEPHRINE (5 MG), CHLORPHENIRAMINE MALEATE (2 MG), PARACETAMOL (250 MG) SYRUP.

Company Profile

ROSEFINCH PHARMACEUTIQUE PVT. LTD. IS A PHARMACEUTICAL COMPANY COMMITTED TO ADVANCING HEALTHCARE THROUGH INNOVATION, QUALITY, AND SCIENTIFIC EXCELLENCE. WE SPECIALIZE IN THE RESEARCH, DEVELOPMENT, MANUFACTURING, AND COMMERCIALIZATION OF HIGH-QUALITY PHARMACEUTICAL FORMULATIONS FOR DOMESTIC AND INTERNATIONAL MARKETS. OUR EXPERTISE SPANS FORMULATION DEVELOPMENT, CONTRACT MANUFACTURING, THIRD-PARTY MANUFACTURING, PRODUCT LICENSING, REGULATORY SUPPORT, AND GLOBAL BUSINESS DEVELOPMENT. WITH A STRONG FOCUS ON THERAPEUTIC AREAS SUCH AS PSYCHIATRY, CARDIOLOGY, DIABETOLOGY, INFLAMMATION, AND COUGH / COLD FORMULATIONS, WE STRIVE TO DELIVER SAFE, EFFECTIVE, AND AFFORDABLE HEALTHCARE SOLUTIONS. BACKED BY ADVANCED R&D CAPABILITIES, WHO-CGMP(JUN-2024) COMPLIANT MANUFACTURING, AND ROBUST QUALITY SYSTEMS, WE ARE DEDICATED TO MEETING GLOBAL REGULATORY STANDARDS. AT ROSEFINCH, WE BUILD LASTING PARTNERSHIPS THROUGH INNOVATION, RELIABILITY, AND A SHARED COMMITMENT TO IMPROVING PATIENT OUTCOMES WORLDWIDE.